Clinical Trials in Michigan

Showing 9701-9720 of 16,154 trials

Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems

NCT02475200

The Phoenix Post-Approval Registry is a prospective, multi-center, single arm registry sponsored by Volcano Corporation to evaluate the short and long term performance and clinical outcomes of the Phoenix Atherectomy System.

Peripheral Arterial DiseaseClaudicationCritical Limb Ischemia

Volcano Corporation500 participantsStarted Sep 2015

Tucson, Arizona, United States • Detroit, Michigan, United States • Saginaw, Michigan, United States +2 more locations

COMPLETEDPhase 330 miles

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

NCT00304031

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving radiation therapy together with temozolomide may kill more tumor cells. It is not yet known which schedule of temozolomide when given together with radiation therapy is more effective in treating glioblastoma or gliosarcoma. PURPOSE: This randomized phase III trial is studying two different schedules of temozolomide to compare how well they work when given together with radiation therapy in treating patients with newly diagnosed glioblastoma or gliosarcoma.

Brain and Central Nervous System Tumors

Radiation Therapy Oncology Group1,173 participantsStarted Jan 2006

Fairbanks, Alaska, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +348 more locations

Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Find Trials by Condition in Michigan

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

LEVANT 2 Safety Registry

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

Canadian Treat and Extend Analysis Trial With Ranibizumab

A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)

Pharmacokinetics of Anti-epileptic Drugs in Obese Children

Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

My Life, My Healthcare

A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302

Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease

Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program

A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma

VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body